Does HDM+ASCT still have a role in frontline MM treatment for all eligible patients? Mohamad Mohty discusses this important question. Should MRD or high-risk status drive our decision? #ESHMM2024 #ESHCONFERENCES #MMsm

Great start of day 2 of #ESHMM2024 ESH (Haematology) with Charlotte Pawlyn setting the scene on frailty biomarkers in older #myeloma patients in session chaired by Prof. Dr. Hermann Einsele Shaji Kumar #MMsm

The criteria for identifying patients with high-risk #MultipleMyeloma has recently been updated!🩸 Hear from Faith E Davies of NYU Langone Health who outlines the changes: 👉 ow.ly/PlEM50TE9j6 👈 #MMSM #Myeloma #HemOnc Myeloma Society

We Suman MITRA and myself are happy to announce the opening of the 8th edition of the international symposium CARTday. We’re going to have 2-day intensive discussions with experts from all over the world.

After an excellent meeting on Waldenstrom put together by Steve and Chris, Dylan Gagler receives his young investigator award

For every £1 of public money invested in the higher education sector, £14 goes back into the economy. Universities power economic growth all over the UK. The government must invest in them to drive the growth mission. See more on the impact of unis👇 loom.ly/T-7pw68

Amazing to see my good friend and a world top expert in #MMsm & transplant & IACH founder dr Mohamad Mohty being recognized with a very well deserved the مؤسسة ومركز الحسين للسرطان life achievement award

My brother-from-another mother and the kindest human and smartest doctor, and easily the number 1 renal oncologist in the world Toni Choueiri, MD from Dana-Farber News receiving a life achievement award at مؤسسة ومركز الحسين للسرطان annual celebration #ArabCancerResearch

Very well deserved recognition of a true role model and one of the most supportive mentors! Congratulations Mohamad Mohty

A recent report from the LWP & EBMT investigated the real-world outcomes of autoSCT in patients with Waldenström’s macroglobulinemia. Charalampia Kyriakou from UCLH shares the findings in a fantastic interview from #IWWM12: 🎥 ow.ly/T08j50U9ROE #LYMsm #Lymphoma #BMTsm

Researchers at the Crick and @UCL have developed an algorithm that can identify which cell populations within a tumour are growing the fastest. The findings are part of the Cancer Research UK-funded TRACERx study and were overseen by Charles Swanton and Simone Zaccaria crick.ac.uk/news-and-repor…

Understanding barriers to enrolment into clinical trials in the UK. Results of a national survey of healthcare professionals and patients. Selina Chavda Sandra Quinn (PhD) Chantelle Hughes RN Dr Pinkie Chambers #ASH24 #mmsm

Very pleased to have presented the first results of our UKMRA ProMMise trial at #ASH24. Showing a response rate of 88% for Belamaf 1.9mg/kg Q8w plus oral weekly cyclophosphamide in relapsed myeloma with median 3 prior lines. Leeds CTRU Myeloma UK #mmsm

🌟 Congratulations to Dr. Éliane Gluckman on receiving the 2024 Wallace H. Coulter Award for Lifetime Achievement in Hematology at #ASH24! A true pioneer in advancing hematology and transforming lives worldwide. youtube.com/watch?v=iqCB8e… Gluckman Mohamad Mohty

Our session on cancer evolution is chaired by Dr Elise Rees Elise Rees and Prof Francesca Ciccarelli Francesca Ciccarelli. Kane Foster Kane Foster has presented his work on the blood-cancer immunity cycle: learning from multiple-myeloma disease evolution. #CRUKCoL2025

The lovely Orla McCourt of UCLH stopped by at #CART25 to share insight into a single-center experience of implementing physiotherapist-led prehabilitation for #CARTCell therapy. Click here to learn more: 👉 ow.ly/ZEtn50UYCM5 #ImmunoOnc #HemOnc The EBMT European Hematology Association

For Rare Disease Day this Friday, we spoke with Sarah Gooding, a clinician scientist in Ross Chapman at the MRC WIMM researching multiple myeloma, a currently incurable type of bone marrow cancer that desperately requires friendlier therapies. Watch: youtu.be/-H16Wd443EI

Evolution of the NK-cell compartment in multiple myeloma and role for bone marrow resident CD56bright NK cells with impaired cytotoxicity in promoting immune evasion Elise Rees Eileen M. Boyle doi.org/10.1101/2025.0…

Less than a week left to submit abstracts for the 3rd London Quantitative Immunology Day! qimmuno.com/ldnday/. Register and share your work with a diverse set of biologists, physicists, mathematicians all united by a common interest in immunology. Ursule Demaël

Very proud of my friend Prof Ali Bazarbachi, a newly elected member of the national academy of medicine in France. ⁦American University of Beirut Medical Center⁩ ⁦Dr. Fadlo Khuri⁩ ⁦IACH⁩ ⁦The EBMT⁩ ⁦HTLV.net⁩ ⁦